BlackRock Investment Management’s Genocea Biosciences, Inc. GNCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $18K | Hold |
532
| – | – | ﹤0.01% | 3392 |
|
|
2016
Q3 | $22K | Hold |
532
| – | – | ﹤0.01% | 3318 |
|
|
2016
Q2 | $17K | Sell |
532
-8,735
| -94% | -$279K | ﹤0.01% | 3411 |
|
|
2016
Q1 | $574K | Buy |
9,267
+210
| +2% | +$13K | ﹤0.01% | 2831 |
|
|
2015
Q4 | $382K | Buy |
9,057
+143
| +2% | +$6.03K | ﹤0.01% | 3082 |
|
|
2015
Q3 | $488K | Buy |
8,914
+855
| +11% | +$46.8K | ﹤0.01% | 3030 |
|
|
2015
Q2 | $885K | Buy |
8,059
+5,988
| +289% | +$658K | ﹤0.01% | 2856 |
|
|
2015
Q1 | $197K | Buy |
2,071
+582
| +39% | +$55.4K | ﹤0.01% | 3214 |
|
|
2014
Q4 | $83K | Hold |
1,489
| – | – | ﹤0.01% | 3327 |
|
|
2014
Q3 | $108K | Sell |
1,489
-3
| -0.2% | -$218 | ﹤0.01% | 3282 |
|
|
2014
Q2 | $224K | Buy |
1,492
+287
| +24% | +$43.1K | ﹤0.01% | 3211 |
|
|
2014
Q1 | $175K | Buy |
+1,205
| New | +$175K | ﹤0.01% | 3228 |
|